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ABSTRACT
The urine albumin creatinine ratio (UACR) detects
abnormal levels of protein in the urine and should be
performed annually to detect kidney disease in patients
with diabetes mellitus. UK national audits show that
25% of patients do not have annual tests and our data
suggested that some patients had more than one test
per year.
Data from 20 patients showed that 55% had more
than one UACR test per year, with a total of 19
unnecessary tests at an estimated cost of £20,000 per
year. However 20% had not had a UACR in the
previous year, so unreliable testing was potentially
causing harm as well as waste. Process mapping
showed that having a UACR test depended on whether
the patient brought a urine sample to the clinic. Most
(72%) patients were unaware that the urine sample
was used to detect kidney damage. We encountered
barriers when finding a process to automate measures
of reliability of UACR testing using computer protocol,
and therefore created a patient information leaflet. The
first version of the leaflet was too technical and several
changes were suggested by patients. After reading the
revised leaflet 99% of patients understood the reason
for UACR testing and 64% felt more motivated to bring
in urine samples. The phlebotomist disseminated the
patient information leaflet with a median of 90%
reliability for six consecutive clinics. The patient
information leaflet has the potential to improve patient
involvement in their care and to increase the number of
patients who bring urine samples to the clinic.
However, this could increase the number of
unnecessary tests unless the process of test ordering
is changed to ensure that UACR is only measured
annually.
PROBLEM
The two key markers for chronic kidney
disease (CKD) are urine albumin and esti-
mated glomerular ﬁltration rate (eGFR).1–3
The UACR is the most reliable screening test
and should be performed yearly to diagnose
and monitor kidney damage in patients with
type 1 diabetes for ﬁve years or more or with
type 2 diabetes.2 Furthermore it is important
to agree the frequency of monitoring UACR,
as patients with, or those who are likely to
develop, the disease must be monitored
more regularly.1
Our team consisted of a consultant diabe-
tologist, the Medical School Lead for Quality
Improvement, the Teaching Lead for Patient
Safety, the phlebotomist and lab technician
working at the diabetes clinic and a third
year medical student. We were concerned
that UACR tests were either being performed
too frequently at the diabetes follow-up clinic
at the Strathmore Diabetes Centre, or not at
all. Baseline data, however, conﬁrmed that
not only did 55% of patients have multiple
UACR tests per year, 20% of patients had
waited more than the recommended 12
months for their next UACR test.
Our main concerns were the waste of
resources caused by too many UACRs and
the potential harm caused by patients having
too few. The two aims of this project were
therefore to: improve the reliability of the
system for UACR testing with the outcome of
reducing waste from excess testing and redu-
cing harm by ensuring all patients have an
annual UACR; involve patients more in their
care with the outcome of their having a
better understanding of kidney disease and
why bringing in urine samples is important.
BACKGROUND
There are 3.3 million people diagnosed with
diabetes in the UK and an estimated 590,000
people who have the condition, but don’t
know it.4 Damage to the kidneys as a result
of diabetes is a signiﬁcant risk factor for the
development of end-stage renal disease and
the need for renal replacement therapy.
Diabetes is the most common cause of estab-
lished renal failure requiring renal replace-
ment therapy. People with diabetes are
almost one and a half times more likely to
need renal replacement therapy than peers
in the general population.5 In the UK, 57%
of patients starting dialysis in 2014 had
diabetes.3 6
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There is evidence that providing a coordinated
approach involving early screening and prompt referral
to specialist teams when necessary, using medications
with proven effectiveness, and increasing patient aware-
ness can reduce the burden of diabetes with kidney
disease.5 However urine testing for albumin was the least
frequently completed of eight key care process in each
of the UK National Diabetes Audits, with only 74% reli-
ability in 2012/20137 and a large cohort study in the
Netherlands found that only 24% of patients with Type
2 diabetes had an annual UACR test and 25% of patients
had never had a test.8 However, although all guidelines
recommend no more than annual tests for UACR to
screen for kidney disease1–3 previous audits of the reli-
ability of care processes have not included the frequency
and cost of unnecessary, additional tests.7 8
BASELINE MEASUREMENT
Two baseline measurements were completed in May
2015. The ﬁrst used SCI-Diabetes, a patient information
database for those with diabetes who live in Scotland.
This measurement assessed the frequency of UACR
testing in 20 patients and found that only 25% of them
had a single UACR test in the previous year, 20% had no
test, and the remaining 55% of patients had more than
one test, with a total of 19 unnecessary additional UACR
tests. The second measurement asked 18 patients, who
were approached during clinic hours, whether they
knew why they need to bring in a urine sample. We
found that 50% did not bring in a urine sample on the
day of their clinic appointment and 85% did not know
why they needed to bring in a sample. Most patients
thought the urine sample was for the monitoring of
sugar or ketones, and others for “diabetes control”.
DESIGN
The ﬁrst method for improvement was to change the
computer programming system at the diabetes centre, so
that the staff are notiﬁed when the annual UACR is due
or if too many have already been done. With this
method, our target was for 95% of patients attending
the clinic to have an annual UACR test in 10 weeks, ie
the scope of the project. This proved difﬁcult due to
time constraints. To change the computer system, we
had to set up multiple meetings weeks in advance with a
number of staff members. This was out of the timeline
for this project and we therefore have no measurements
for this intervention.
A second method was used to improve the involve-
ment of patients in their care and their understanding
of why kidney disease is an important complication of
diabetes. We did this by handing out a patient informa-
tion leaﬂet (Supplementary Material 1 - Run Chart
Summary, Slide 9) and, by doing so, we assumed that
patients would be self-motivated to ensure they had
received an annual UACR test. To prove this, we would
have to wait for these patients to return to the clinic in
six months time and take measurements, which was
beyond the scope of the project. By the time we had
developed our second method, we had only three weeks
remaining. We would like to undertake a future project
to look at this.
The following measurements are from the second
intervention only:
Process: the percentage of patients that were handed
the information leaﬂet by the phlebotomist
Outcome: the percentage of patients who understood
why they were asked to bring a urine sample to the
clinic before and after reading the leaﬂet; patient satis-
faction with the kidney disease information leaﬂet (%);
patients’ motivation to bring in a urine sample after
reading the information leaﬂet (%)
Balancing: the percentage of patients who had con-
cerns about the kidney disease information leaﬂet and
time required for staff to hand out the kidney disease
information leaﬂet or answer questions from patients.
The patient information leaﬂet was a single A4 sheet
printed in black and white. This was given to each
patient by the phlebotomist along with a urine sample
pot for the next clinic appointment. It was anticipated
that sustainability might be compromised by the need to
print out information sheets before clinic starts. There is
a large printer in the clinic that is used frequently by
the receptionist so her support is critical. In the future,
we will ask for NHS Tayside’s agreement to print the
leaﬂet, which will greatly improve sustainability. The
leaﬂet was approved by the consultants in the clinic and
followed the NHS Tayside patient information protocol.
The patients were asked to read the leaﬂet during the
waiting time at the clinic, and were asked the following
questions before they left the clinic:
a. Do you bring a urine sample to every clinic?
b. Do you understand more about kidneys and diabetes
after reading the kidney disease leaﬂet?
c. Have you found reading this leaﬂet has raised any
concerns? If yes, please specify.
d. Are you more motivated to bring in a urine sample
to your next appointment?
STRATEGY
Process mapping was used to identify opportunities for
giving the information leaﬂet to patients and measuring
how much time they had to read the leaﬂet in the clinic
(Supplementary Material 1 - Run Chart Summary, Slide
3).
Plan Do Study Act (PDSA) cycles were used to test
changes (Supplementary Material 2 - PDSA Cycles - Sets
1 and 2). There are two sets of cycles. The ﬁrst is
entitled “PDSA Cycles, Intervention: Introduce a patient
information leaﬂet about kidney disease and the value
of UACR measurement as a screening test.” The second,
“PDSA Cycles, Original intervention: Introduce a com-
puter protocol for annual testing of UACR, rather than
automatic testing whenever a patient brings in a urine
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sample.” We have summarised the two PDSA cycle sets
below.
PDSA Cycles, Intervention: Introduce a patient infor-
mation leaﬂet about kidney disease and the value of
UACR measurement as a screening test:
The patient information leaﬂet was written following
NHS Tayside patient information guidelines and
approved by staff before it was tested with 10 patients in
one clinic (PDSA Cycle 1, Intervention). The medical
student handed the leaﬂets to the patients while they
were having blood taken. There was not enough time
for the patient to read the leaﬂet and patients seemed
very disinterested in the information. The leaﬂet
received poor patient feedback: the wording was too
technical, e.g. “microalbuminuria”, and this stopped
patients from understanding the information; some
patients did not think having knowledge of kidney
disease is important; as soon as the patients looked at
the leaﬂet, they seemed disengaged (unattractive
layout).
The design and wording of the leaﬂet was improved
after PDSA Cycle 1, and kept the same from PDSA Cycle
2 onwards. The word “microalbuminuria” was removed
and replaced by “protein in the urine”, and other
wording was simpliﬁed to make for easier reading. More
pictures were added and text was deleted to provide
more empty space on the page. Bold text was used to
highlight important words (“damage”, “albumin”), and
repetition of important ideas e.g. “damaged blood
vessels […] become leaky” were repeated so the patients
could consolidate what they have learned.
This improved leaﬂet was given to the patients by the
phlebotomist, instead of the medical student. She
explained what the urine sample was for and told the
patients to read the information before being asked
them questions in the waiting room. This increased
patient compliance to read the leaﬂet as they regard the
phlebotomist as a friend. Feedback for this leaﬂet was
very positive, and all patients said the leaﬂet was easy to
read and understandable. Most patients felt more moti-
vated to bring in urine samples having learned more
about kidney disease and why it’s important to bring
one in. Patients who did not feel more motivated
already knew about kidney disease. Two patients had not
brought in a urine sample for a long time, and they
described themselves as being highly motivated to bring
them in after reading the leaﬂet - both of these patients
said it gave them new information and that they would
ask their doctor for advice on UACR testing.
PDSA Cycles, Original intervention: Introduce a com-
puter protocol for annual testing of UACR, rather than
automatic testing whenever a patient brings in a urine
sample:
The need for a better system of UACR testing was
agreed by the consultants in the clinic, with the caution
that patients with abnormal UACR test results should
have more than one UACR test per year.1–3 The medical
student had a meeting with the lab technician and from
this created guidelines for the lab technician to give to
her supervisor, so that the computer protocol could be
changed. However, her supervisor suggested meetings
with different staff members that were set for a few
weeks’ time. This was outwith the project timeline. We
estimated the cost of unnecessary UACR tests for
patients attending the Strathmore Clinic to be £423 per
week, which adds up to £22,004 per year
(Supplementary Material 3 – BMJ Cost Savings
Calculator).
RESULTS
The ﬁrst version of the leaﬂet only achieved 20% patient
satisfaction (Supplementary Material 1 - Run Chart
Summary, Slide 4) and had no impact on patient under-
standing or motivation (Supplementary Material 1 - Run
Chart Summary, Slides 5 and 6). The information
proved to be too technical and the layout discouraged
patients from reading it as it had too much text -
reading it was a demanding task.
After redesigning the leaﬂet content and distribution,
95% of patients understood why their urine was tested
and being more motivated to bring in a urine sample to
their next appointment (Supplementary Material 1 -
Run Chart Summary, Slides 5 and 6). All of the patients
said that the leaﬂet was helpful, and patients commen-
ted that they liked being given more information about
how diabetes may affect them and that information
about kidney disease information was a good idea.
Handout of patient leaﬂets by the phlebotomist was a
reliable process (Supplementary Material 1 - Run Chart
Summary, Slide 7) and also enabled discussion with
patients about the leaﬂet content. As expected, during the
three weeks of testing the information leaﬂet there was no
change in the % of patients who brought urine samples to
the clinic, which ﬂuctuated from 40-90% (Supplementary
Material 1 - Run Chart Summary, Slide 8).
LESSONS AND LIMITATIONS
The medical student found that leading an improve-
ment project had several important learning outcomes.
First, identifying and involving key-stakeholders, like the
phlebotomist and the lab technician, was vital to
running tests on suggestions for improvement. It would
not have been possible to sustain the information leaf-
lets without the phlebotomist agreeing to hand them
out, and her encouraging patients to read the informa-
tion was a great help to gathering data. Second, spend-
ing 10 weeks in the clinic led to the development of
friendships with the staff members, and for this reason it
became easier to work together as a team. Third, the
work was patient-centred and talking to patients in the
waiting room gave better insights into patient experi-
ence than sitting in on consultations with the diabetolo-
gist. Finally, the barriers to improving the reliability of
UACR testing were excellent learning opportunities for
systems thinking.
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At the same time, the lead investigator being a
medical student caused difﬁculty in gaining access to
patient data on UACR testing from SCI-Diabetes, which
we needed for our initial measurements of how many
patients have an annual UACR, and being able to
receive patient feedback. We addressed this by: applying
to the Caldicott Guardians for NHS Tayside to be
granted access to look at patient data on SCI-Diabetes;
applying to the University Research Ethics Committee
(UREC) for approval to ask patients for feedback and
publish the data gathered from this; establishing the
need for a reliable, transparent policy on ethics and gov-
ernance of improvement projects in NHS Tayside.
However, the project length was 10 weeks, and the
current systems of applying for approval stopped work
being done for long periods of time. The difﬁculty we
encountered with the UACR data was not that the infor-
mation is unavailable – it is all uploaded onto
SCI-Diabetes – but that we could not access the hub of
data because we lacked the necessary permissions.
The restrictions of being a medical student, with
regard to accessing data and even being allowed to ask
patients for feedback were time-consuming and required
a lot of effort to overcome. The need for a clear policy
for governance and registration of student and Early
Career Professional improvement projects has been
recognised by the Academic Health Sciences
Partnership in Tayside and included in their Better
Professional Development programme.9 This work will
be led by NHS Tayside’s Head of Clinical Governance.
We have also reviewed and questioned our results. We
need a larger cohort of patients to ensure this is not the
case. After reading the information leaﬂet, patients were
asked by the medical student for their opinion on the
content. The student introduced herself as part of the
team who created the leaﬂet, and therefore the patients
may have felt biased to speak more highly of it. In future
studies, the student will not mention his or her connec-
tion to the leaﬂet. Confounding factors were identiﬁed
as the friendliness of the medical student and the vari-
ation in intelligence of the patients. Future studies will
ensure the students introduce themselves and only ask
the required questions, so patients do not feel obliged
to be more positive about the leaﬂet because they like
the student. Patients may not have fully understood the
leaﬂet before commenting on its effectiveness, so a short
questionnaire may be helpful to show that patients are
giving reliable feedback. A small number of the 2000
patients attending the diabetes centre were questioned
about the leaﬂet and we did not perform statistical
testing. Our results could therefore be due to chance.
We would like to undertake ongoing measurement and
statistical testing on a greater number of patients in the
future.
The leaﬂet is sustainable, as it requires one sheet of
paper with black and white ink, which can be printed in
bulk, to be available to the phlebotomist. In this study,
she handed the leaﬂet to the patients but patients'
taking the leaﬂet as they leave the room should also be
tested. This will then save the phlebotomist time and the
patients can read the leaﬂet while they wait for their
appointment with the consultant. The sustainability of
this project relies upon the willingness of the phlebot-
omist to ask patients to read the leaﬂet and leaﬂets
always being present in her room. To ensure this, we
hope to later have the leaﬂet printed by NHS Tayside. In
this vein, we also hope that the leaﬂet can be handed
out in multiple NHS hospitals as we feel it is generalised
– it is written in a way that the patients we tested under-
stand, from whom we had very positive feedback.
It was not possible to make changes to the UACR com-
puter protocol within the short time available for this
project. System change will require collaboration
between the quality improvement team, the staff in the
diabetes clinical, and the biochemistry staff and meet-
ings will take place in the future.
CONCLUSION
The two aims of this project were to: improve the reli-
ability of the system for UACR testing with the outcome
of reducing waste from excess testing and reducing
harm by ensuring all patients have an annual UACR;
involve patients more in their care with the outcome of
their having a better understanding of kidney disease
and why bringing in urine samples is important.
We achieved the second aim but not the ﬁrst. We were
therefore unsure about the consequences of further
implementation of the information leaﬂet. Increasing
awareness of kidney disease and the importance of urine
samples should encourage patients to bring in a sample,
which could reduce harm by ensuring patients have an
annual UACR. However, this would probably increase
the number of excess tests if more patients bring in
samples and no computer protocol is in place to ensure
only one annual test. Whilst it is possible that the leaﬂet
could educate patients on the need for one test a year,
we thought it more likely that the information leaﬂet
would increase waste in the absence of a reliable system
for eliminating unnecessary repeat tests.
Overall, our project has been successful at improving
patient awareness of kidney disease and encouraging
them to bring in samples. Our ﬁnding that 20% of
patients attending the clinic had not had an UACR test
in the previous year is consistent with the UK National
Diabetes Audit ﬁndings, in which 25% of patients did
not have an annual test.7 There was no improvement in
the reliability of UACR testing from 2010-13,7 so our
information leaﬂet has the potential to close an import-
ant gap in the quality of care for patients with diabetes.
However, previous audits have not measured waste from
unnecessary UACR tests7 8 and we estimated that even in
one clinic this was costing NHS Tayside £20,000 per year
(Supplementary Material 3 – BMJ Cost Savings
Calculator). Our project shows that a simple information
leaﬂet can have a positive impact on patient education.
4 Willison A, et al. BMJ Quality Improvement Reports 2016;5:u209185.w3747. doi:10.1136/bmjquality.u209185.w3747
Open Access
group.bmj.com on October 26, 2016 - Published by http://qir.bmj.com/Downloaded from 
We suggest that other diabetes clinics check whether
their patients know about kidney disease and think
about creating an information leaﬂet to aid their under-
standing but that they should also look at the reliability
of their systems for eliminating unnecessary repeat
UACR tests.
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